Profil
Michael Listgarten is General Counsel at ALX Oncology Holdings, Inc. since 2026.
Formerly, General Counsel at Rapt Therapeutics, Inc. from 2023 to 2026, Vice President-Healthcare Law at Principia Biopharma, Inc. in 2020, and VP-Healthcare Law & Chief Compliance Officer at Adamas Pharmaceuticals LLC in 2021.
Education includes graduate studies at The Trustees of Columbia University in The City of New York and undergraduate studies at the University of Pennsylvania.
Aktive Positionen von Michael Listgarten
| Unternehmen | Position | Beginn |
|---|---|---|
| ALX ONCOLOGY HOLDINGS INC. | General Counsel | 30.06.2026 |
Ehemalige bekannte Positionen von Michael Listgarten
| Unternehmen | Position | Ende |
|---|---|---|
| RAPT THERAPEUTICS, INC. | General Counsel | 03.03.2026 |
| ADAMAS PHARMACEUTICALS, INC. | Compliance Officer | 01.11.2021 |
| PRINCIPIA BIOPHARMA INC. | Corporate Officer/Principal | 01.12.2020 |
Ausbildung von Michael Listgarten
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Adamas Pharmaceuticals LLC
Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
Principia Biopharma, Inc.
Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a R&D driven and AI-powered biopharma company | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rapt Therapeutics, Inc.
Rapt Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes oral small molecule therapies for patients | Health Technology |
ALX Oncology Holdings, Inc.
ALX Oncology Holdings, Inc. BiotechnologyHealth Technology Operates as clinical stage immuno-oncology company, which develops therapies for cancer | Health Technology |
















